Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ypeginterferon alfa-2b and GM-CSF in Chronic Hepatitis B
NCT02332473Phase 2Completed
- Sponsor
- Xiamen Tebao Biological Engineering Co., Ltd.
- Start
- Jun 2014
- Primary completion
- Feb 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of granulocyte macrophage-colony stimulating factor in Chronic Hepatitis B (CHB), sponsored by Xiamen Tebao Biological Engineering Co., Ltd.. Started Jun 2014; status: completed.
02
Drugs
granulocyte macrophage-colony stimulating factor
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT02332473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02332473.